Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05427916 · ClinicalTrials.gov registry record · NA
Closed Incision Negative Pressure Wound Therapy vs. Foam as Post Operative Dressing
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05427916 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants.
The verdict
NCT05427916, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective is to assess the frequency of a wound healing complication, in a closed incisional wound in a "high risk" surgical incision when treated with Negative Pressure Wound Therapy versus a highly absorbent antimicrobial post - operative absorbent dressing.
Interventions
- DEVICE Avance Solo
- OTHER Optifoam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2023-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05427916
The ClinicalTrials.gov registry entry for NCT05427916 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Avance Solo is the first listed.
NCT05427916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05427916 about?
NCT05427916 is a clinical study titled "Closed Incision Negative Pressure Wound Therapy vs. Foam as Post Operative Dressing". The primary objective is to assess the frequency of a wound healing complication, in a closed incisional wound in a "high risk" surgical incision when treated with Negative Pressure Wound Therapy versus a highly absorbent antimicrobial post - operative absorbent dressing.
What is the current status of trial NCT05427916?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2022-07-12. Estimated completion is 2023-02-17.
What interventions are being tested in trial NCT05427916?
The interventions under investigation include: Avance Solo (DEVICE), Optifoam (OTHER).
Who is sponsoring clinical trial NCT05427916?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.